SCHEMBL7436834

SCHEMBL7436834

O=C1CCN(CC(=O)NC2CCCCCCC2)CC1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 6/20 0.65
CHRM5 P08912 3/20 0.65
CHRM3 P20309 2/20 0.65
CA12 O43570 2/20 0.60
CA1 P00915 2/20 0.60
CA2 P00918 2/20 0.60
CA9 Q16790 2/20 0.60
ALDH1A1 P00352 2/20 0.56
MAPK1 P28482 1/20 0.56
L3MBTL1 Q9Y468 1/20 0.55
LMNA P02545 1/20 0.54
TSHR P16473 1/20 0.54
CHRM1 P11229 2/20 0.54
CHRM2 P08172 1/20 0.54
CHRM4 P08173 1/20 0.54
GAA P10253 1/20 0.52
DRD4 P21917 1/20 0.52
DRD3 P35462 1/20 0.52
KMT2A Q03164 1/20 0.52
CYP3A4 P08684 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7438034 1.00 SIGMAR1 (0.65) SIGMAR1CHRM5CHRM3CA12CA1
SCHEMBL7446957 0.92 SIGMAR1 (0.53) SIGMAR1CHRM5CHRM3CA12CA1
SCHEMBL6479844 0.84 SIGMAR1 (0.75) SIGMAR1CHRM5CHRM3CA12CA1
SCHEMBL23612751 0.80 SIGMAR1 (0.71) SIGMAR1CHRM5CHRM3CA12CA1
SCHEMBL19034848 0.80 SIGMAR1 (0.71) SIGMAR1CHRM5CHRM3CA12CA1
SCHEMBL19636761 0.80 SIGMAR1 (0.71) SIGMAR1CHRM5CHRM3CA12CA1
SCHEMBL2930549 0.79 SIGMAR1 (0.67) SIGMAR1CHRM5CHRM3CA12CA1
SCHEMBL11010870 0.79 SIGMAR1 (0.91) SIGMAR1CHRM5CHRM3CA12CA1
SCHEMBL10304524 0.79 SIGMAR1 (0.67) SIGMAR1CHRM5CHRM3CA12CA1
Esaprazole SCHEMBL931007 0.79 SIGMAR1 (1.00) SIGMAR1CHRM5CHRM3CA12CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4499100-A CARDIOUVASCULAR DISORDERS SYNTEX (U.S.A.) INC. (US) 1985-02-12 US disclosed